588 filings
Page 5 of 30
CORRESP
pwjry0otf 2ua54y0w
27 Jan 17
Correspondence with SEC
12:00am
DEFA14A
jowvav3ek 59x18bqm
27 Jan 17
Additional proxy soliciting materials
12:00am
CORRESP
kv1bcf858z7tx8d
25 Jan 17
Correspondence with SEC
12:00am
4
5kglxm8gei 0q8l1yxah
9 Jan 17
PROVECTUS BIOPHARMACEUTICALS / PETER R CULPEPPER ownership change
12:00am
SC 13D
3mexs6
5 Jan 17
Provectus Biopharmaceuticals, Inc.
12:00am
8-K
we6hp9p9i t7
28 Dec 16
Departure of Directors or Certain Officers
12:00am
UPLOAD
66cu8ahs m1cyfwpt3g
19 Dec 16
Letter from SEC
12:00am
CORRESP
ojld fj82v22c1
19 Dec 16
Correspondence with SEC
12:00am
8-K
nni90y2tykut2kme0j1
8 Dec 16
Provectus Biopharmaceuticals Announces Agreement with Poetic
12:00am
8-K
du2tpu un
30 Nov 16
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
jz97 scqfdtxg6yno1
28 Nov 16
Submission of Matters to a Vote of Security Holders
12:00am
CORRESP
tmwxk
22 Nov 16
Correspondence with SEC
12:00am
DEFA14A
mz7tc hlc0bm
18 Nov 16
Additional proxy soliciting materials
12:00am
UPLOAD
1ybtn0le l3s74ztp
16 Nov 16
Letter from SEC
12:00am
8-K
fp5p738tryl
14 Nov 16
Regulation FD Disclosure
12:00am